Trial Profile
Prospective, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil 600 mg PO, BID for 10 Days Versus Clarithromycin in the Treatment of Community-Acquired Pneumonia.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 15 Nov 2011
Price :
$35
*
At a glance
- Drugs Faropenem medoxomil (Primary) ; Clarithromycin
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Adverse reactions; Therapeutic Use
- 25 Jul 2011 New trial record